Emi Kimoto
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Pharmacological Effects and Toxicity Studies, Liver Disease Diagnosis and Treatment, Drug-Induced Hepatotoxicity and Protection
Most-Cited Works
- → Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions(2012)359 cited
- → Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population(2003)352 cited
- → Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19(2021)288 cited
- → Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data(2012)241 cited
- → Preferential Stiffening of Central Over Peripheral Arteries in Type 2 Diabetes(2003)216 cited
- → Body fat mass and lean mass as predictors of survival in hemodialysis patients(2006)170 cited